1. Hand-foot-skin reaction related to use of the multikinase inhibitor sorafenib and hard orthotics
    Ayan Kusari et al, 2018, Pediatric Dermatology CrossRef
  2. Advancement of All-Trans Retinoic Acid Delivery Systems in Dermatological Application
    Sharifah Shakirah Syed Omar et al, 2022, Cosmetics CrossRef
  3. Adverse reactions and adherence to capecitabine: A prospective study in patients with gastrointestinal cancer
    Marília B Visacri et al, 2022, Journal of Oncology Pharmacy Practice CrossRef
  4. Uracil-tegafur vs fluorouracil as postoperative adjuvant chemotherapy in Stage II and III colon cancer
    Po-Huang Chen et al, 2021, Medicine CrossRef
  5. Breast cancer: insights in disease and influence of drug methotrexate
    Vítor Yang et al, 2020, RSC Medicinal Chemistry CrossRef
  6. Management of skin adverse reactions in oncology
    Diva Silva et al, 2020, Journal of Oncology Pharmacy Practice CrossRef
  7. A Case Report of Capecitabine-Associated Bowel Inflammation With a Novel Mutation of the DPYD Gene
    Lukas Schlager et al, 2020, AJSP: Reviews and Reports CrossRef
  8. Ichthyosiform Pityriasis Rubra Pilaris-Like Eruption Secondary to Ponatinib Therapy: Case Report and Literature Review
    Ariel E. Eber et al, 2017, Drug Safety - Case Reports CrossRef
  9. Topical Retinoids: Therapeutic Mechanisms in the Treatment of Photodamaged Skin
    Ryan R. Riahi et al, 2016, American Journal of Clinical Dermatology CrossRef
  10. Detection of capecitabine (Xeloda®) on the skin surface after oral administration
    Mao-Dong Huang et al, 2016, Journal of Biomedical Optics CrossRef
  11. Carotenoids in Human Skin In Vivo: Antioxidant and Photo-Protectant Role against External and Internal Stressors
    Maxim E. Darvin et al, 2022, Antioxidants CrossRef